PRS2 A COST-MINIMIZATION ANALYSIS COMPARING MOXIFLOXACIN VERSUS LEVOFLOXACIN AND CEFTRIAXONE FOR THE TREATMENT OF PATIENTS HOSPITALIZED WITH COMMUNITY-ACQUIRED PNEUMONIA- RESULTS FROM THE MOTIVTRIAL
Abstract
Authors
AC Lloyd AJ Hoi man